Evidence map›Paper›PMID 27075243›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2016

Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor.

Li Kong, Yun-Peng Zhao, Qing-Yun Tian, Jian-Quan Feng, Tatsuya Kobayashi, Joseph Merregaert, Chuan-Ju Liu

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Atsttrin Promotes Cartilage Repair Primarily Through TNFR2-Akt Pathway.Frontiers in cell and developmental biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Li KongDepartment of Orthopedic Surgery, New York University School of Medicine, New York, New York, USA;
Yun-Peng ZhaoDepartment of Orthopedic Surgery, New York University School of Medicine, New York, New York, USA;
Qing-Yun TianDepartment of Orthopedic Surgery, New York University School of Medicine, New York, New York, USA;
Jian-Quan FengDepartment of Biomedical Sciences, Texas A&M Baylor College of Dentistry, Dallas, Texas, USA;
Tatsuya KobayashiEndocrine Unit, Massachusetts General Hospital, Boston, Massachusetts, USA;
Joseph MerregaertLaboratory of Molecular Biotechnology, University of Antwerp, Antwerp, Belgium;
Chuan-Ju LiuDepartment of Orthopedic Surgery, New York University School of Medicine, New York, New York, USA; Department of Cell Biology, New York University School of Medicine, New York, New York, USA chuanju.liu@med.nyu.edu.
New York University · USBaylor University · USMassachusetts General Hospital · USUniversity of Antwerp · BE

Funding

The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1R01AR062207 · NIAMS · YALE UNIVERSITY · PI Chuanju Liu · 2012 to 2026
$5.6M
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1 - Revision - 2R01AR061484 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2011 to 2020
$4.8M
Role of miR-17-92 miRNAs in skeletal development and bone homeostasisR01AR056645 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI KOBAYASHI, TATSUYA · 2010 to 2020
$4.1M
NIAMS NIH HHS R01 AR056645NIAMS NIH HHS R01 AR061484NIAMS NIH HHS R01 AR062207
6 · The paper itself

Abstract

Chondrogenesis and endochondral ossification are precisely controlled by cellular interactions with surrounding matrix proteins and growth factors that mediate cellular signaling pathways. Here, we report that extracellular matrix protein 1 (ECM1) is a previously unrecognized regulator of chondrogenesis. ECM1 is induced in the course of chondrogenesis and its expression in chondrocytes strictly depends on parathyroid hormone-related peptide (PTHrP) signaling pathway. Overexpression of ECM1 suppresses, whereas suppression of ECM1 enhances, chondrocyte differentiation and hypertrophy in vitro and ex vivo In addition, target transgene of ECM1 in chondrocytes or osteoblasts in mice leads to striking defects in cartilage development and endochondral bone formation. Of importance, ECM1 seems to be critical for PTHrP action in chondrogenesis, as blockage of ECM1 nearly abolishes PTHrP regulation of chondrocyte hypertrophy, and overexpression of ECM1 rescues disorganized growth plates of PTHrP-null mice. Furthermore, ECM1 and progranulin chondrogenic growth factor constitute an interaction network and act in concert in the regulation of chondrogenesis.-Kong, L., Zhao, Y.-P., Tian, Q.-Y., Feng, J.-Q., Kobayashi, T., Merregaert, J., Liu, C.-J. Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor.

Indexed as

AnimalsChondrogenesisExtracellular Matrix ProteinsGene Expression Regulation, DevelopmentalGranulinsIntercellular Signaling Peptides and ProteinsMice, TransgenicOsteogenesisParathyroid Hormone-Related ProteinProgranulinsEcm1 protein, mouseExtracellular Matrix ProteinsGranulinsGrn protein, mouseIntercellular Signaling Peptides and ProteinsParathyroid Hormone-Related ProteinProgranulinsECM1PGRNPTHrP

Identifiers

PMID27075243
PMCPMC4970607
OpenAlexW2339065539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.